| human | Q5 |
| P227 | GND ID | 1173295283 |
| P496 | ORCID iD | 0000-0002-3073-7463 |
| P214 | VIAF ID | 20154500074039091206 |
| P69 | educated at | Cornell University | Q49115 |
| Case Western Reserve University | Q1047060 | ||
| P108 | employer | University of Southern California | Q4614 |
| Case Western Reserve University | Q1047060 | ||
| P734 | family name | Schumacher | Q1773921 |
| Schumacher | Q1773921 | ||
| Schumacher | Q1773921 | ||
| P735 | given name | Fredrick | Q21147789 |
| Fredrick | Q21147789 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q33848895 | 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy |
| Q31154835 | A Bayesian latent class analysis for whole-genome association analyses: an illustration using the GAW15 simulated rheumatoid arthritis dense scan data |
| Q46378338 | A common 8q24 variant in prostate and breast cancer from a large nested case-control study |
| Q35755874 | A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer |
| Q33980349 | A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians |
| Q35957063 | A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density |
| Q35093501 | A genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer |
| Q29417059 | A genome-wide association meta-analysis identifies new childhood obesity loci |
| Q36395306 | A genome-wide association study for colorectal cancer identifies a risk locus in 14q23.1. |
| Q35669222 | A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32. |
| Q35177444 | A genome-wide pleiotropy scan for prostate cancer risk |
| Q33566592 | A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival |
| Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
| Q35248192 | A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer |
| Q36435849 | A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. |
| Q36477652 | A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease |
| Q35655831 | A model to determine colorectal cancer risk using common genetic susceptibility loci |
| Q34558031 | A systematic mapping approach of 16q12.2/FTO and BMI in more than 20,000 African Americans narrows in on the underlying functional variation: results from the Population Architecture using Genomics and Epidemiology (PAGE) study. |
| Q61948757 | Abstract 4836: Gene and environment interactions of height and selected candidate SNPs in prostate cancer: results from the PRACTICAL consortium |
| Q57785674 | Abstract LB-282: Transethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A |
| Q61948762 | Abstract LB-448: Genome-wide association study identifies new prostate cancer susceptibility loci |
| Q34472668 | Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium |
| Q24170413 | Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types |
| Q97070156 | Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers |
| Q57305944 | Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q36123803 | Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses |
| Q35246178 | Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants |
| Q37127877 | Association of the FTO obesity risk variant rs8050136 with percentage of energy intake from fat in multiple racial/ethnic populations: the PAGE study |
| Q63966080 | Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
| Q64118820 | Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
| Q60907509 | Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry |
| Q35852637 | Body Mass Index Genetic Risk Score and Endometrial Cancer Risk |
| Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
| Q39734134 | Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States |
| Q44449983 | CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). |
| Q33616702 | CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium |
| Q36750746 | CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk |
| Q24169697 | Characterization of large structural genetic mosaicism in human autosome |
| Q33842251 | Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3. |
| Q57796257 | Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study |
| Q36000794 | Colorectal cancer linkage on chromosomes 4q21, 8q13, 12q24, and 15q22. |
| Q94486442 | Combined associations of a polygenic risk score and classical risk factors with breast cancer risk |
| Q35868793 | Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3) |
| Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
| Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
| Q36979100 | Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer |
| Q51622312 | Common variants in the obesity-associated genes FTO and MC4R are not associated with risk of colorectal cancer. |
| Q29417133 | Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk |
| Q89499516 | Comparative Effectiveness of Local and Systemic Therapy for T4 Prostate Cancer |
| Q30907474 | Comparison of missing data approaches in linkage analysis |
| Q33519251 | Copy number variation in the Framingham Heart Study |
| Q46112906 | Correction to: Transethnic insight into the genetics of glycaemic traits: fine-mapping results from the Population Architecture using Genomics and Epidemiology (PAGE) consortium |
| Q55257640 | Correction: Colorectal Cancer Linkage on Chromosomes 4q21, 8q13, 12q24, and 15q22. |
| Q50240714 | Corrigendum: genome-wide association study of colorectal cancer identifies six new susceptibility loci. |
| Q28396029 | Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer |
| Q28388475 | Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations |
| Q34096825 | Cross-cancer pleiotropic analysis of endometrial cancer: PAGE and E2C2 consortia |
| Q34441746 | Defining the role of common variation in the genomic and biological architecture of adult human height |
| Q23916196 | Detectable clonal mosaicism and its relationship to aging and cancer |
| Q60472142 | Discovery of common and rare genetic risk variants for colorectal cancer |
| Q34338886 | Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer |
| Q30494721 | Evaluation of 8q24 and 17q risk loci and prostate cancer mortality |
| Q30494853 | Evaluation of the 8q24 prostate cancer risk locus and MYC expression. |
| Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
| Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
| Q27908479 | Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome |
| Q37217089 | Fine Mapping and Identification of BMI Loci in African Americans |
| Q37164415 | Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility |
| Q35056055 | Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer |
| Q36068167 | Fine-Mapping of Common Genetic Variants Associated with Colorectal Tumor Risk Identified Potential Functional Variants |
| Q30371049 | Fine-mapping IGF1 and prostate cancer risk in African Americans: the multiethnic cohort study. |
| Q36856343 | Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression |
| Q55380382 | Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. |
| Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
| Q55311842 | Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. |
| Q35097143 | Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer |
| Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
| Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
| Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
| Q37629802 | Generalization and fine mapping of European ancestry-based central adiposity variants in African ancestry populations |
| Q35999323 | Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study |
| Q37281843 | Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer |
| Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
| Q22305005 | Genetic studies of body mass index yield new insights for obesity biology |
| Q52561250 | Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies. |
| Q28392218 | Genetic variants associated with fasting glucose and insulin concentrations in an ethnically diverse population: results from the Population Architecture using Genomics and Epidemiology (PAGE) study |
| Q33777217 | Genetic variation across C-reactive protein and risk of prostate cancer |
| Q34094981 | Genetic variation in RNASEL associated with prostate cancer risk and progression |
| Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
| Q36422109 | Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium |
| Q35218136 | Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality |
| Q36741744 | Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium |
| Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
| Q45068755 | Genome-wide association study and meta-analysis in Northern European populations replicate multiple colorectal cancer risk loci |
| Q28924380 | Genome-wide association study identifies new prostate cancer susceptibility loci |
| Q37140021 | Genome-wide association study of colorectal cancer identifies six new susceptibility loci |
| Q28660394 | Genome-wide association study of endometrial cancer in E2C2 |
| Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
| Q29614925 | Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 |
| Q35009643 | Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. |
| Q35399770 | Genome-wide association study of prostate cancer mortality |
| Q38970751 | Genome-wide association study of prostate cancer-specific survival |
| Q29417001 | Genome-wide diet-gene interaction analyses for risk of colorectal cancer |
| Q58611475 | Germline variation at 8q24 and prostate cancer risk in men of European ancestry |
| Q58605247 | Growth factor genes and change in mammographic density after stopping combined hormone therapy in the California Teachers Study |
| Q31047674 | HNF1B and endometrial cancer risk: results from the PAGE study |
| Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
| Q37649043 | Identification and characterization of functional risk variants for colorectal cancer mapping to chromosome 11q23.1. |
| Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
| Q29417155 | Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array |
| Q29416993 | Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis |
| Q37008880 | Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk |
| Q36069872 | Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer |
| Q36198138 | Identification of a new prostate cancer susceptibility locus on chromosome 8q24. |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q57170142 | Identification of nine new susceptibility loci for endometrial cancer |
| Q36014067 | Identification of novel genetic markers of breast cancer survival |
| Q36331604 | Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions |
| Q28275237 | Identification of ten loci associated with height highlights new biological pathways in human growth |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q23924183 | Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33 |
| Q33758994 | Incorporating prior biologic information for high-dimensional rare variant association studies |
| Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
| Q55693698 | Insulin-like Growth Factor Pathway Genetic Polymorphisms, Circulating IGF1 and IGFBP3, and Prostate Cancer Survival. |
| Q36849912 | Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). |
| Q33845203 | Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival |
| Q36065460 | Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions |
| Q36077025 | Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate |
| Q90358834 | Large-Scale Genome-Wide Association Study of East Asians Identifies Loci Associated With Risk for Colorectal Cancer |
| Q35119669 | Large-scale fine mapping of the HNF1B locus and prostate cancer risk |
| Q29417030 | Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk |
| Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
| Q91750919 | Lifetime Occurrence of Brain Metastases Arising from Lung, Breast, and Skin Cancers in the Elderly: A SEER-Medicare Study |
| Q37046338 | Meta-analysis identifies four new loci associated with testicular germ cell tumor |
| Q34091855 | Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development |
| Q35670184 | Meta-analysis of new genome-wide association studies of colorectal cancer risk |
| Q30977635 | Methodological Considerations in Estimation of Phenotype Heritability Using Genome-Wide SNP Data, Illustrated by an Analysis of the Heritability of Height in a Large Sample of African Ancestry Adults |
| Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
| Q40513382 | Modeling disease risk through analysis of physical interactions between genetic variants within chromatin regulatory circuitry |
| Q33925293 | Multiancestral analysis of inflammation-related genetic variants and C-reactive protein in the population architecture using genomics and epidemiology study |
| Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
| Q28943507 | Multiple loci identified in a genome-wide association study of prostate cancer |
| Q35646703 | Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans |
| Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
| Q56359054 | Novel Common Genetic Susceptibility Loci for Colorectal Cancer |
| Q91720911 | Observed racial disparity in the negative predictive value of multi-parametric MRI for the diagnosis for prostate cancer |
| Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
| Q91467292 | Perceptions of Prostate MRI and Fusion Biopsy of Radiation Oncologists and Urologists for Patients Diagnosed with Prostate Cancer: Results from a National Survey |
| Q37570238 | Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q33726756 | Polymorphism in endostatin, an angiogenesis inhibitor, and prostate cancer risk and survival: A prospective study |
| Q33733210 | Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q41584352 | Prediction of individual genetic risk to prostate cancer using a polygenic score |
| Q37103045 | Prostate Cancer Susceptibility in Men of African Ancestry at 8q24 |
| Q37735483 | Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium |
| Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
| Q90242034 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers |
| Q24656179 | Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3) |
| Q36009422 | RAD51B in Familial Breast Cancer |
| Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
| Q33835331 | Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2. |
| Q79365894 | Relation of serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 to risk of prostate cancer (United States) |
| Q33756733 | Replication of associations between GWAS SNPs and melanoma risk in the Population Architecture Using Genomics and Epidemiology (PAGE) Study. |
| Q35661241 | Replication of five prostate cancer loci identified in an Asian population--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). |
| Q35815958 | Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci |
| Q29417074 | Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study |
| Q61118451 | Shared heritability and functional enrichment across six solid cancers |
| Q64004349 | Shared heritability and functional enrichment across six solid cancers |
| Q28397509 | Telomere structure and maintenance gene variants and risk of five cancer types |
| Q34331070 | Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. |
| Q37578078 | The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers |
| Q35558999 | The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort |
| Q33708730 | Toll-like receptor signaling pathway variants and prostate cancer mortality |
| Q38845982 | Trans-ethnic fine-mapping of genetic loci for body mass index in the diverse ancestral populations of the Population Architecture using Genomics and Epidemiology (PAGE) Study reveals evidence for multiple signals at established loci |
| Q34270911 | Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A. |
| Q46929705 | Trans-fatty acid intake and increased risk of advanced prostate cancer: modification by RNASEL R462Q variant. |
| Q40041955 | Transethnic insight into the genetics of glycaemic traits: fine-mapping results from the Population Architecture using Genomics and Epidemiology (PAGE) consortium |
| Q43051933 | Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry. |
| Q42366130 | Up For A Challenge (U4C): Stimulating innovation in breast cancer genetic epidemiology |
| Q79428722 | Vitamin D receptor genotypes/haplotypes and prostate cancer risk |
| Q39051789 | seXY: a tool for sex inference from genotype arrays |
Search more.